* Medifast Inc MED.N MED is expected to show a rise in
quarterly revenue when it reports results on February 23.
* The Owings Mills Maryland-based company is expected to
report
a 41.9% increase in revenue to $375.794 million from $264.91
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $2.65 per share. For the same quarter last year, the
company reported earnings of $2.36 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$345, about 48.7% above its last closing price of $177.06.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 3.09 3.08 3.56 Beat 15.6
Jun. 30 2021 3.36 3.32 3.96 Beat 19.4
Mar. 31 2021 2.74 2.73 3.46 Beat 26.9
Dec. 31 2020 2.37 2.38 2.36 Missed -0.8
Sep. 2.54 2.46 2.91 Beat 18.5
30 2020
Jun. 30 2020 1.84 1.83 1.96 Beat 7
Mar. 31 2020 1.31 1.33 1.93 Beat 45.4
Dec. 31 2019 1.08 1.07 1.66 Beat 54.5
This summary was machine generated February 22 at 02:22 GMT.
All figures in US dollars unless otherwise stated